Management of abnormal serum markers in the absence of aneuploidy or neural tube defects

References

• Brock DJ, Sutcliffe RG. α-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet 1972;2:197–199.
   PubMed Web of Science ®Google Scholar
• Harris R, Jennison RF, Barson AJ, Laurence KM, Ruoslahti E, Seppälä M. Comparison of amniotic-fluid and maternal serum α-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly. Lancet 1974;1:428–429.
   PubMedGoogle Scholar
• Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886–894.
   PubMed Web of Science ®Google Scholar
• Simpson JL, Baum LD, Marder R, Elias S, Ober C, Martin AO. Maternal serum α-fetoprotein screening: low and high values for detection of genetic abnormalities. Am J Obstet Gynecol 1986;155:593–597.
   PubMedGoogle Scholar
• Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL et al.; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 2005;353:2001–2011.
   PubMed Web of Science ®Google Scholar
• Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, et al. First-trimester maternal serum PAPP-A and free-β subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004;191:1446–1451.
   PubMed Web of Science ®Google Scholar
• Spong CY, Ghidini A, Walker CN, Ossandon M, Pezzullo JC. Elevated maternal serum midtrimester α-fetoprotein levels are associated with fetoplacental ischemia. Am J Obstet Gynecol 1997;177:1085–1087.
   PubMedGoogle Scholar
• Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn 2010;30:293–308.
   PubMed Web of Science ®Google Scholar
• Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, et al.; First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004;191:1452–1458.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2008;31:15–19.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 2008;31:147–152.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Avgidou K, Nicolaides KH. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Ultrasound Obstet Gynecol 2006;28:637–643.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 2008;28:7–10.
   PubMed Web of Science ®Google Scholar
• Dugoff L; Society for Maternal-Fetal Medicine. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes. Obstet Gynecol 2010;115:1052–1061.
   PubMed Web of Science ®Google Scholar
• van Rijn M, van der Schouw YT, Hagenaars AM, Visser GH, Christiaens GC. Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening. Obstet Gynecol 1999;94:929–934.
   PubMedGoogle Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–381.
   PubMed Web of Science ®Google Scholar
• Restrepo RD, Fortenberry JD, Spainhour C, Stockwell J, Goodfellow LT. Protocol-driven ventilator management in children: comparison to nonprotocol care. J Intensive Care Med 2004;19:274–284.
   PubMedGoogle Scholar
• Baschat AA, Weiner CP. Umbilical artery Doppler screening for detection of the small fetus in need of antepartum surveillance. Am J Obstet Gynecol 2000;182:154–158.
   PubMed Web of Science ®Google Scholar
• Ajayi RA, Soothill PW, Campbell S, Nicolaides KH. Antenatal testing to predict outcome in pregnancies with unexplained antepartum haemorrhage. Br J Obstet Gynaecol 1992;99:122–125.
   PubMedGoogle Scholar
• Aquilina J, Thompson O, Thilaganathan B, Harrington K. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol 2001;17:477–484.
   PubMed Web of Science ®Google Scholar
• Bromley B, Frigoletto FD Jr, Harlow BL, Pauker S, Benacerraf BR. The role of Doppler velocimetry in the structurally normal second-trimester fetus with elevated levels of maternal serum α-fetoprotein. Ultrasound Obstet Gynecol 1994;4:377–380.
   PubMedGoogle Scholar
• Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free β-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 2005;25:949–953.
   PubMed Web of Science ®Google Scholar
• Bower S, Bewley S, Campbell S. Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993;82:78–83.
   PubMed Web of Science ®Google Scholar
• Huerta-Enochian G, Katz V, Erfurth S. The association of abnormal α-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome? Am J Obstet Gynecol 2001;184:1549–53; discussion 1553.
   PubMedGoogle Scholar